Literature DB >> 23784678

[Urine marker systems for diagnosis of urothelial cancer].

S Tritschler1, F Strittmatter, A Karl, C Stief.   

Abstract

Cystoscopy and urinary cytology are standard tools in the diagnostics of urothelial cancer of the urinary bladder; however, cystoscopy is invasive and urinary cytology lacks accuracy for the diagnosis of low grade tumors. More recently several alternative urinary test systems were developed with the aim to make the diagnostics of urothelial tumors more reliable; however, in general all protein-based point of care test systems have a high rate of false positive test results, especially in patients with benign disorders. Fluorescence in situ hybridization, which is highly sensitive and specific, may be a reasonable supplement to the diagnostic spectrum in patients after instillation therapy or bladder replacement. Additionally, there are several new test systems which still need to be tested in large clinical studies with respect to diagnostic accuracy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784678     DOI: 10.1007/s00120-013-3227-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  36 in total

Review 1.  Urine markers for detection and surveillance of non-muscle-invasive bladder cancer.

Authors:  Derya Tilki; Maximilian Burger; Guido Dalbagni; H Barton Grossman; Oliver W Hakenberg; Juan Palou; Oliver Reich; Morgan Rouprêt; Shahrokh F Shariat; Alexandre R Zlotta
Journal:  Eur Urol       Date:  2011-06-12       Impact factor: 20.096

2.  Urinary cytology in era of fluorescence endoscopy: redefining the role of an established method with a new reference standard.

Authors:  Stefan Tritschler; Maria-Luisa Sommer; Julia Straub; Yasemin Hocaoglu; Derya Tilki; Frank Strittmatter; Dirk Zaak; Christian Stief; Alexander Karl
Journal:  Urology       Date:  2010-09       Impact factor: 2.649

3.  Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis.

Authors:  Stefan Tritschler; Sonja Scharf; Alexander Karl; Derya Tilki; Ruth Knuechel; Arndt Hartmann; Christian G Stief; Dirk Zaak
Journal:  Eur Urol       Date:  2006-08-15       Impact factor: 20.096

4.  A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine.

Authors:  Johanna M M van Oers; Irene Lurkin; Antonius J A van Exsel; Yvette Nijsen; Bas W G van Rhijn; Madelon N M van der Aa; Ellen C Zwarthoff
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

Review 5.  Urine markers for bladder cancer surveillance: a systematic review.

Authors:  Bas W G van Rhijn; Henk G van der Poel; Theo H van der Kwast
Journal:  Eur Urol       Date:  2005-03-23       Impact factor: 20.096

6.  Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.

Authors:  Shahrokh F Shariat; Caroline Savage; Thomas F Chromecki; Maxine Sun; Douglas S Scherr; Richard K Lee; Giovanni Lughezzani; Mesut Remzi; Michael J Marberger; Pierre I Karakiewicz; Andrew J Vickers
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

7.  Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.

Authors:  Chris H Bangma; Stacy Loeb; Martijn Busstra; Xiaoye Zhu; Samira El Bouazzaoui; Jeanine Refos; Kirstin A Van Der Keur; Stephen Tjin; Conja G A M Franken; Geert J L H van Leenders; Ellen C Zwarthoff; Monique J Roobol
Journal:  Eur Urol       Date:  2013-03-04       Impact factor: 20.096

Review 8.  Survivin: a promising biomarker for detection and prognosis of bladder cancer.

Authors:  Vitaly Margulis; Yair Lotan; Shahrokh F Shariat
Journal:  World J Urol       Date:  2007-10-26       Impact factor: 4.226

9.  Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions.

Authors:  Dirk Zaak; Edwin Hungerhuber; Peter Schneede; Herbert Stepp; Dominic Frimberger; Stefan Corvin; Nikolaus Schmeller; Martin Kriegmair; Alfons Hofstetter; Ruth Knuechel; Ruth Knöchel
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

10.  A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.

Authors:  Morgan Rouprêt; Vincent Hupertan; David R Yates; Eva Comperat; James W F Catto; Mark Meuth; Amine Lackmichi; Sylvie Ricci; Roger Lacave; Bernard Gattegno; François Richard; Freddie C Hamdy; Olivier Cussenot
Journal:  BJU Int       Date:  2008-03-04       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.